Regulation
Meetings, optimism on patent reform, but no pact
WASHINGTON (Reuters) - High tech companies and drug companies agree that U.S. patent reform will pass soon, but there is considerably less agreement on what it should look like.
Securitization seen needing time, oversight
WASHINGTON (Reuters) - After a spree with subprime mortgages, the hung-over securitized debt market will need time and a firm hand to sober up, said a range of U.S. banking regulators and lawmakers this week.
Senate nears vote on product safety overhaul
WASHINGTON (Reuters) - The Senate may vote as soon as next week on a bill to reform product safety regulation after months of recalls of shoddy goods, many of them toys made in China, said a key lawmaker and Senate aides on Thursday.
2nd engine for F-35 would improve quality: Levin
WASHINGTON (Reuters) - The head of the Senate Armed Services Committee said on Friday he would examine a Pentagon decision to again cancel funding for a second F-35 Joint Strike Fighter engine, but said he remained convinced an alternate engine would improve competition and quality in the long run.
Senator sees credit card action this year
WASHINGTON (Reuters) - Congress is likely to move toward final legislation this year to reform often-criticized marketing and billing practices by credit card companies, a senior U.S. lawmaker said on Friday.
US lawmaker targets offshore tax evaders
WASHINGTON (Reuters) - Wealthy Americans dodge more than $100 billion a year in taxes by hiding assets in the Cayman Islands and other offshore tax havens, said a senior lawmaker on Friday who is trying to put a stop to it.
OTS chief not aware of any WaMu deal
WASHINGTON (Reuters) - A top U.S. banking regulator said on Thursday he is not aware of any pending deals involving Washington Mutual Inc , the largest U.S. savings and loan.
Countrywide rumors in January wrong: OTS
WASHINGTON (Reuters) - Wall Street rumors in January that Countrywide Financial Corp might seek bankruptcy protection were wrong, senior U.S. banking regulators said on Thursday.
Medicare chief stands by anemia move
WASHINGTON (Reuters) - A senior Medicare official said the case for restricting payments for anemia drugs sold by Amgen Inc and Johnson & Johnson has become stronger since the agency made its controversial decision.
Audit watchdog to home in on "fair value"
WASHINGTON (Reuters) - Hard to value financial instruments such as mortgage-backed securities will be scrutinized for any auditing failures when the latest crop of annual reports are inspected, the chairman of the Public Company Accounting Oversight Board said on Thursday.
Futures markets seen akin to "Sodom and Gomorrah"
WASHINGTON (Reuters) - Crude oil traders bear more blame for record-high prices than big oil companies like Exxon Mobil Corp , a key House lawmaker said on Thursday.
Speakers
| Summit | Date | Category |
|---|---|---|
| Islamic Banking and Finance | Feb 15 - 18 | Country Summits |
| Travel and Leisure | Feb 22 - 24 | Hotels/Casinos |
| Private Equity and Hedge Funds | Mar 1 - 3 | Financial Services/Exchanges |
| Global Mining and Steel | Mar 8 - 10 | Mining |
| Food and Agriculture | Mar 15 - 18 | Mining |
| Canadian Oil Sands | Mar 22 - 23 | Energy |
| Funds | Mar 23 - 24 | Financial Services/Exchanges |
| Global Exchanges and Trading | Mar 29 - 31 | Financial Services / Exchanges |
| Financial Regulation | Apr 26 - 29 | Financial Services / Exchanges |





